Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country setting. Issue 10 (28th February 2020)
- Record Type:
- Journal Article
- Title:
- Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country setting. Issue 10 (28th February 2020)
- Main Title:
- Application of a cost-effectiveness analysis of pathogen-specific vaccines against gastroenteritis to a military population in a developing country setting
- Authors:
- Ballard, Sarah-Blythe
Tallant, Aaron
Guerra, Rosio G.
Quigley, Dawn
Stiegmann, Regan
Mirelman, Andrew J.
Riddle, Mark S.
Gilman, Robert H. - Abstract:
- Highlights: Vaccine cost-effectiveness modeling can inform LMIC military health policies. Enteropathogen vaccines may be cost-effective for special LMIC adult populations. Shigella and norovirus vaccines appear cost-effective for Peruvian troops. Abstract: Vaccine implementation planning in low- and middle-income countries (LMIC) often focuses on children without considering special adult populations. We adapted an economic model developed by the United States Department of Defense (DoD) to evaluate the cost-effectiveness of vaccine acquisition strategies for Campylobacter-, ETEC-, Shigella-, and norovirus-associated gastroenteritis. We compared implementation costs with current medical management in the Peruvian armed forces, a special population of low- and middle-income (LMIC) adults with a high incidence of infectious gastroenteritis. Pathogen-specific vaccine implementation resulted in calculated cost-effectiveness ratio (CER) per duty day lost averted (CERDDL ) of $13, 741; $1, 272; $301; and $803, and a CER per diarrhea day averted of $2, 130; $215; $51; and $199 for Campylobacter, ETEC, Shigella, and norovirus, respectively. These estimates compare favorably to CERDDL estimates from high-income military population and suggest that implementing vaccines gastroenteritis may be cost-effective in the Peruvian military population.
- Is Part Of:
- Vaccine. Volume 38:Issue 10(2020)
- Journal:
- Vaccine
- Issue:
- Volume 38:Issue 10(2020)
- Issue Display:
- Volume 38, Issue 10 (2020)
- Year:
- 2020
- Volume:
- 38
- Issue:
- 10
- Issue Sort Value:
- 2020-0038-0010-0000
- Page Start:
- 2292
- Page End:
- 2297
- Publication Date:
- 2020-02-28
- Subjects:
- Gastroenteritis -- Vaccine -- Cost-effectiveness analysis -- Low- and middle-income countries -- Military -- Peru
Vaccines -- Periodicals
615.372 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0264410X ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0264410X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0264410X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.vaccine.2020.01.075 ↗
- Languages:
- English
- ISSNs:
- 0264-410X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9138.628000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 12911.xml